Procter & Gamble (NYSE:PG – Get Free Report) had its price objective boosted by stock analysts at Barclays from $160.00 to $161.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Barclays‘s target price would indicate a potential upside of 4.76% from the company’s current price.
Several other analysts have also commented on the company. Redburn Atlantic lowered Procter & Gamble from a “buy” rating to a “neutral” rating and set a $161.00 price objective on the stock. in a report on Thursday, May 1st. Truist Financial lowered their price target on Procter & Gamble from $185.00 to $180.00 and set a “buy” rating on the stock in a research note on Friday, April 25th. Bank of America lowered their price target on Procter & Gamble from $190.00 to $180.00 and set a “buy” rating on the stock in a research note on Friday, April 25th. Morgan Stanley set a $180.00 price target on shares of Procter & Gamble and gave the stock an “overweight” rating in a research note on Friday, April 25th. Finally, Evercore ISI reissued an “in-line” rating and issued a $170.00 price target (down from $190.00) on shares of Procter & Gamble in a research note on Monday. Nine investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $177.25.
Check Out Our Latest Stock Analysis on Procter & Gamble
Procter & Gamble Stock Up 0.7%
Procter & Gamble (NYSE:PG – Get Free Report) last issued its quarterly earnings data on Thursday, April 24th. The company reported $1.54 EPS for the quarter, beating the consensus estimate of $1.53 by $0.01. Procter & Gamble had a return on equity of 32.67% and a net margin of 18.46%. The company had revenue of $19.78 billion for the quarter, compared to analyst estimates of $20.42 billion. During the same period last year, the company earned $1.52 earnings per share. Procter & Gamble’s quarterly revenue was down 2.1% compared to the same quarter last year. Analysts predict that Procter & Gamble will post 6.91 earnings per share for the current fiscal year.
Insider Activity
In other Procter & Gamble news, CEO Jennifer L. Davis sold 1,000 shares of the company’s stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total transaction of $161,380.00. Following the sale, the chief executive officer owned 51,965 shares in the company, valued at $8,386,111.70. This represents a 1.89% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Moses Victor Javier Aguilar sold 10,520 shares of the company’s stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $158.67, for a total value of $1,669,208.40. Following the sale, the insider owned 25,182 shares in the company, valued at approximately $3,995,627.94. This trade represents a 29.47% decrease in their position. The disclosure for this sale can be found here. 0.18% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Procter & Gamble
Several large investors have recently bought and sold shares of PG. Kingstone Capital Partners Texas LLC increased its holdings in shares of Procter & Gamble by 655,209.0% in the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after acquiring an additional 76,017,350 shares during the last quarter. Norges Bank purchased a new position in shares of Procter & Gamble in the 4th quarter valued at about $5,244,463,000. Nuveen LLC purchased a new position in shares of Procter & Gamble in the 1st quarter valued at about $1,954,941,000. GAMMA Investing LLC increased its holdings in shares of Procter & Gamble by 20,758.5% in the 1st quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company’s stock valued at $1,355,087,000 after acquiring an additional 7,913,335 shares during the last quarter. Finally, Capital Research Global Investors increased its holdings in shares of Procter & Gamble by 62.5% in the 4th quarter. Capital Research Global Investors now owns 7,398,120 shares of the company’s stock valued at $1,240,294,000 after acquiring an additional 2,846,560 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
- Five stocks we like better than Procter & Gamble
- What is Insider Trading? What You Can Learn from Insider Trading
- 3 Stocks to Cushion Your Portfolio This Earnings Season
- Energy and Oil Stocks Explained
- This Fund Manager Says You Should Get Out of Tesla and Apple—Now
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.